Comparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study

Background: Mice receiving angiotensin converting enzyme inhibitor (ACEI) drugs show increased susceptibility to infection by Staphylococcus aureus ( S. aureus). We sought to investigate whether humans using ACEI were at increased risk of S. aureus infection, comparing them to users of Angiotensin I...

Descripción completa

Detalles Bibliográficos
Autores principales: Bidulka, Patrick, Iwagami, Masao, Mansfield, Kathryn E., Kalogirou, Fotini, Wong, Angel Y. S., Douglas, Ian J., Smeeth, Liam, Summers, Charlotte, Tomlinson, Laurie A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262569/
https://www.ncbi.nlm.nih.gov/pubmed/32529041
http://dx.doi.org/10.12688/wellcomeopenres.15873.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262569/
https://www.ncbi.nlm.nih.gov/pubmed/32529041
http://dx.doi.org/10.12688/wellcomeopenres.15873.1

Ejemplares similares